missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ Reversan

Beschreibung
Reversan is a selective inhibitor of multidrug resistance-associated protein 1 (MRP1) and P-glycoprotein (P-gp). Increases the sensitivity of MRP1-overexpressing tumor cells (MCF7/VP) to doxorubicin (Cat. No. 2252), vincristine (Cat. No. 1257) and etoposide (Cat. No. 1226) by 3.8-, 14.6- and 11.6-fold respectively. Increases the efficacy of vincristine and etoposide in murine models of neuroblastoma in vivo. Does not sensitize MRP2, MRP3, MRP4 or MRP5 transporters to known substrates.
Spezifikation
Spezifikation
| Menge | 10 mg |
| Produkttyp | Reversan |
| Reinheit | 0.95 |
| Molekulargewicht | 441.52 |
| Hemmstoffe | Reversan |
Nur für Forschungszwecke
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?